BIVDA helped to formulate the new NICE Diagnostic Pathology Impact Report and we welcome its publication – we look forward to working with NICE and NHS England stakeholders on making even more progress to improve services.Our External Affairs team has produced a briefing on the report, highlighting its recommendations and future action for engaging with stakeholders, including BIVDA.Links to reports cited in the briefing are as follows:Early Detection and Diagnosis of Cancer RoadmapTh...

£30 million is to be invested in postgraduate training courses for doctors, to ensure the NHS has access to skills necessary in managing the patient care backlog from the pandemic. Many postgraduate trainees have postponed their study in order to work on the frontline. This funding will be manifested in a tailored approach, based on the individual needs of trainees, including one-to-one training conversations and recovery plans. As many as 123,800 doctors and over 303,000 nurses are now wo...

BIVDA Digital Working Party Reminder Register here.  10:30     Welcome, introductions and competition law      10.35     Overview of the IVD development pathway and how CPI can help commercialise digital IVD devices using their in-house capabilities and expertise          UK CPI (catapult)10.55   Digital Revolution Industry paper final drafting Helen Dent, BIVDA11.35&...

Press Release                                                                                 &...

A new national public health procurement scheme has gone live to speed up access to supplies and build threat resilience. The new microbiology framework will help to grow capacity, push innovation and build resilience within the microbiology supply chain. The framework is open to all public sector, academic and charitable bodies. It will help to ensure labs and other diagnostic and treatment services have easier and faster access to essential supplies. The framework was designed by Public Health...

The British In-Vitro Diagnostic Association (BIVDA) has launched the first in a series of strategy papers, which will assess what the UK IVD industry needs to grow and thrive in the future. The first of these papers ’Emerging from the Pandemic – An Industry View’ examines what needs to be done to lock in our progress in developing systems to cope with infectious diseases. The outbreak of SARS-CoV-2 first detected in China in December 2019 has been challenging for countries...

NHS Confederation has announced the launch of a new network for GP Federations as it seeks to unite federation managers across the UK and support members with tailored products such as bulletins, briefings and events. This will allow chairs, chief operating officers, and other senior federation managers to interconnect, co-operate on issues and share resources. Ensuring the ongoing support of primary care during the pandemic, while it copes with the NHS backlog from lockdown pauses, will be an e...

The Government is preparing to launch trade agreement negotiations with Canada and Mexico in the latest phase of post-Brexit consolidation of global trade relationships. A call for input is being put out to UK businesses and the public ahead of the talks formally starting. Consultation with a wide variety of trading stakeholders, citizens and industry bodies will allow for the UK to put its best foot forward at the talks, which are scheduled to begin later this year. In 2020, the UK agreed deals...

The United Kingdom has shared some objectives for the COP26 event in November with Central American countries in a regional event. The British Ambassador in Guatemala, Nick Whittingham, led discussion from the UK side at the virtual opening of the French – Central American talks on climate change, organized by the Government of France, the Guatemalan Ministry of Foreign Affairs and the countries of the System of Central American Integration (SICA). The UK will host the 26th UN Climate Chan...

IPSWICH, MA (May 10th, 2021) — New England Biolabs, Inc. (NEB®), a leading supplier of life science reagents, today announces that it has entered into an agreement to acquire Fluorogenics Limited (FGL), a lyophilization R&D service company based in the UK. Under the terms of the agreement, FGL will become a wholly-owned subsidiary of NEB. With the point-of-care market becoming more focused on the development of robust, accurate and cost-effective diagnostic tests for use outsi...